ResMed Inc. (ASX:RMD)

Market Cap	56.43B
Revenue (ttm)	7.95B
Net Income (ttm)	2.17B
Shares Out	n/a
EPS (ttm)	14.77
PE Ratio	25.96
Forward PE	22.61
Dividend	0.50 (1.32%)
Ex-Dividend Date	Aug 13, 2025

Volume	524,093
Average Volume	1,463,077
Open	38.75
Previous Close	38.35
Day's Range	38.55 - 38.80
52-Week Range	32.04 - 45.25
Beta	0.83
RSI	39.75
Earnings Date	Oct 30, 2025

About ResMed

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1989
• Employees: 10,600
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: RMD

Financial Performance

In 2025, ResMed's revenue was $5.15 billion, an increase of 9.84% compared to the previous year's $4.69 billion. Earnings were $1.40 billion, an increase of 37.20%.

Financial numbers in USD